| Crystal structure of human BAZ2A PHD zinc finger in complex with unmodified H3 10-mer | |
Heteromer
P68431; | 1675-1728 | 100 | 2×ZN; 1×PO4; |
|
| Crystal structure of human BAZ2A | | homo-2-mer | 541-649 | 100 | 22×UNX; |
|
| The TAM domain of BAZ2A in complex with a 12mer mCG DNA | | homo-2-mer | 543-650 | 100 | 1×GOL; |
|
| Crystal structure of BAZ2A with DNA | | homo-2-mer | 544-650 | 100 | 12×UNX; |
|
| Crystal structure of BAZ2A with DNA | | homo-2-mer | 544-650 | 100 | 12×UNX; |
|
| Crystal structure of human BAZ2A PHD zinc finger in the free form | | homo-2-mer | 1676-1728 | 100 | 4×ZN; 1×PO4; 1×GOL; |
|
| Solution structure of the TAM domain of human TIP5 BAZ2A involved in epigenetic regulation of rRNA … | | monomer | 543-650 | 100 | |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 79 | | monomer | 1796-1899 | 98.08 | 2×GKI; |
|
| Crystal structure of human BAZ2A bromodomain in complex with a diacetylated histone 4 peptide (H4K1… | | monomer | 1796-1899 | 100 | |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 77 | | monomer | 1796-1898 | 98.06 | 2×GGQ; |
|
| BAZ2A bromodomain in complex with triazole compound MS04-TN02 | | monomer | 1796-1898 | 98.06 | 1×T1H; |
|
| BAZ2A bromodomain in complex with triazole compound MS04-TN03 | | monomer | 1796-1898 | 98.06 | 1×T3H; |
|
| BAZ2A bromodomain in complex with GSK2801 chemical probe | | monomer | 1796-1898 | 100 | 1×3WQ; 1×EDO; |
|
| BAZ2A bromodomain in complex with triazole compound MS04 | | monomer | 1796-1898 | 98.06 | 1×T1B; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 63 | | monomer | 1796-1898 | 98.06 | 2×G1U; |
|
| BAZ2A bromodomain in complex with compounds MS04 and B11 | | monomer | 1796-1898 | 98.06 | 1×T1B; 1×T1E; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 88 | | monomer | 1796-1898 | 98.06 | 1×GJC; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 65 | | monomer | 1796-1898 | 98.06 | 1×G2U; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 44 | | monomer | 1796-1898 | 98.06 | 1×FWR; 1×EDO; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 78 | | monomer | 1796-1898 | 98.06 | 2×GQF; |
|
| BAZ2A bromodomain in complex with triazole compound MS04-TN04 | | monomer | 1796-1898 | 98.06 | 1×T8Z; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 104 | | monomer | 1796-1898 | 98.06 | 1×GEJ; 1×MG; |
|
| Crystal Structure of BAZ2A bromodomain in complex with acetylindole compound UZH47 | | monomer | 1796-1898 | 100 | 1×UO1; 1×MG; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 83 | | monomer | 1796-1898 | 98.06 | 2×GQX; 1×MG; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 3-amino-2-methylpyridine derivative 1 | | monomer | 1796-1898 | 100 | 1×6RZ; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridine derivative 1 | | monomer | 1796-1898 | 100 | 1×7MX; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 109 | | monomer | 1796-1898 | 98.06 | 1×GJ4; 1×MG; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 45 | | monomer | 1796-1898 | 100 | 1×FS6; 2×EDO; 1×MG; |
|
| BAZ2A bromodomain in complex with N-acetylpiperazine derivative fragment 18 | | monomer | 1796-1898 | 100 | 1×GI7; 1×EDO; 1×MG; |
|
| BAZ2A bromodomain in complex with GSK4027 chemical probe | | monomer | 1796-1898 | 98.06 | 1×9ST; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 4-propionyl-pyrrole derivative 2 | | monomer | 1796-1898 | 100 | 1×7MW; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 47 | | monomer | 1796-1898 | 98.06 | 1×EDO; 1×GIE; 1×MG; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 1,3-dimethyl-benzimidazolone compound 1 | | monomer | 1796-1898 | 100 | 1×JR4; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative fragment 25 | | monomer | 1796-1898 | 100 | 1×FIY; 1×MG; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 1 | | monomer | 1796-1898 | 100 | 1×D8Q; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 61 | | monomer | 1796-1898 | 100 | 1×G0I; |
|
| BAZ2A bromodomain in complex with the chemical probe BAZ2-ICR | | monomer | 1796-1898 | 100 | 1×U1Z; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 3 | | monomer | 1796-1898 | 100 | 1×D9T; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 3-amino-2-methylpyridine derivative 2 | | monomer | 1796-1898 | 100 | 1×D9K; |
|
| BAZ2A bromodomain in complex with picolinamide derivative fragment 13 | | monomer | 1796-1898 | 100 | 1×EDO; 1×FI5; |
|
| BAZ2A bromodomain in complex with pyridone derivative fragment 36 | | monomer | 1796-1898 | 100 | 1×FI9; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 4 | | monomer | 1796-1898 | 100 | 1×D9Q; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 2 | | monomer | 1796-1898 | 100 | 1×EN2; |
|
| BAZ2A bromodomain in complex with TP-238 chemical probe | | monomer | 1797-1898 | 98.04 | 1×WCS; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 113 | | monomer | 1797-1898 | 98.04 | 1×GHL; 1×EDO; 1×MG; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 111 | | monomer | 1797-1898 | 98.04 | 1×GIJ; 1×MG; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 98 | | monomer | 1797-1898 | 98.04 | 1×EDO; 1×GI0; |
|
| BAZ2A bromodomain in complex with isoquinoline derivative fragment 9 | | monomer | 1797-1898 | 100 | 1×GIU; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 87 | | monomer | 1797-1898 | 98.04 | 1×GIZ; 1×EDO; |
|
| BAZ2A bromodomain in complex with compound UP39 | | monomer | 1797-1898 | 100 | 2×U2E; |
|
| BAZ2A bromodomain in complex with compound UZH23 | | monomer | 1797-1898 | 100 | 2×U2K; |
|
| BAZ2A bromodomain in complex with acetylpyrrole derivative compound 80 | | monomer | 1797-1898 | 98.04 | 2×GJI; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 1-methylpyridinone compound 5 | | monomer | 1799-1899 | 100 | 1×D9B; |
|
| Crystal structure of the bromodomain of human BAZ2A | | monomer | 1799-1898 | 100 | 4×EDO; 1×MG; |
|
| Crystal Structure of BAZ2A bromodomain in complex with 4-chloropyridine derivative 3 | | monomer | 1799-1898 | 100 | 1×7MU; |
|
| Crystal Structure of BAZ2A bromodomain in complex with acetophenone derivative 4 | | monomer | 1799-1898 | 100 | 1×7MZ; |
|
| Crystal structure of human BAZ2A PHD zinc finger in complex with unmodified H3K4 histone peptide | | monomer | 1673-1728 | 100 | 2×ZN; 1×EDO; |
|
| Crystal structure of BAZ2A PHD zinc finger in complex with Fr 19 | | monomer | 1676-1728 | 100 | 2×ZN; 1×PO4; 1×K; |
|
| Crystal structure of BAZ2A PHD zinc finger in complex with H3 10-mer AA mutant peptide | | monomer | 1676-1728 | 100 | 2×ZN; 1×PO4; |
|
| Crystal structure of human BAZ2A PHD zinc finger in complex with Fr23 | | monomer | 1676-1728 | 100 | 2×ZN; 1×PO4; |
|
| Crystal structure of BAZ2A PHD zinc finger in complex with H3 3-mer peptide | | monomer | 1677-1728 | 100 | 2×ZN; 1×PO4; |
|